FOLR1 and ovarian carcinoma: This study provides the first multicenter assessment of FOLR1 expression in Polish ovarian cancer in the context of treatment eligibility.<h4>Methods</h4>We retrospectively analyzed two institutional cohorts comprising 229 epithelial ovarian cancer cases from the Oncology Center in Bydgoszcz and the National Institute of Oncology in Warsaw.